Belimumab 400mg powder for solution for infusion vials
- SNOMED code
19482111000001102- Active compound
- Belimumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Belimumab
— 400 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd)
in short Benlysta 400mg pdr for concentrate for inf vials
Benlysta 400mg powder for concentrate for solution for infusion vials
- SNOMED code
19480311000001104- Supplier
- GlaxoSmithKline UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial19480411000001106 ref. pack | 💯 Available Legal category: POM | 5000123113866End: 500012311493105054290002836End: 5054290010787 | NHS Indicative Price £405 | • Personally Administered • Hospital |
| — |
Reference packs
Belimumab 400mg powder for solution for infusion vials 1 vial
- SNOMED code
19480211000001107- Quantity and unit
- 1 vial
- Packs